Clinical Trial Update: Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results for a combination of pemetrexed and gemcitabine in metastatic breast cancer patients who have received taxane therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Alimta (pemetrexed)
• Gemzar (gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer, Breast Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2009-05-13